| |
| Magyar Neuroszonológiai Társaság |
|
| 2025 World Pediatrics Conference |
 Rendezvény kezdete: 2025.10.10. | Rendezvény vége: 2025.10.11. |
| Szakterület(ek): Nukleáris Medicina, Sebészet, Gyermekgyógyászat, Kardiológia, Orvosi informatika, Diabetológia |
| Tudományos információ: Silvia Morris |
| Munkahely neve: Episirus Scientifica |
| Címe: USA, 19803 1521 Concord Pike Ste 301, 246 |
| Tel: +13024401610 |
| E-mail: pediatrics@episirus.org |
| Szervező: Silvia Morris |
| Címe: USA, |
| E-mail: pediatrics@episirus.org |
| Helyszín: Singapore, Singapore, Singapore, Episirus Scientifica |
| A rendezvény Web oldala: https://pediatrics.episirus.org/ |
Episirus Scientifica welcomes you to attend the 2025 World Paediatrics Conference
(2025WPC) which is going to be held during October 10–11, 2025, in Singapore around the
theme ‘Innovating Pediatric Care for a Healthier Future’ accredited with CPD credits which
enable the professionals from worldwide to exchange their views on a wide variety of topics
affecting child care and those suffering from pediatric diseases around the world. Since
Genetic variance, developmental issues and Congenital defects are of a greater concern to
pediatricians, we will be exploring more into these fields. This international meet
(2025WPC) anticipates hundreds of participants including keynote speakers, Oral
presentations by renowned speakers and poster presenters besides delegates around the
world. This conference perhaps a giant event that creates an ideal platform to share
expertise addressing current advancements involved in Pediatric and Neonatal care. It will
be a wonderful opportunity for all the delegates as it provides an international networking
opportunity to collaborate with the world-class Pediatric and Medical Associations.
Few Topics which will be covered:
Pediatric Biochemistry
Pediatric Epilepsy
Pediatric Genetics
Neonatology and Pediatric Intensive Care
Pediatric Infectious Diseases
Pediatric Neuroradiology
Child Nutrition
Pediatric Immunology
Pediatric Allergy and Dermatology
Pediatric Cardiology
Pediatric Psychology and Adolescent Medicine
Pediatric Neurology
Pediatric Hematology and Oncology
Pediatric Emergencies and many more
Target Audience:
Pediatrician
Pediatirc Cardiologists
Pediatric Neurologists
Pediatric Researchers
Pediatric Scientists
Pediatric Nurses
Pediatric Dermatologists
Pediatric Faculty
Medical Colleges
Pediatric Physicians
Training Institutes
Industry professionals
Researchers
Fellows or Postdoctoral Students
Therapists
Emeritus
Young Research Scientists
Business Delegates
Medical Students
Device Manufacturing Companies
Pediatric Associations and Societies
|
|
|
 |
| |
| Magyar Immunológiai Társaság |
|
| DC2012 - 12th International Symposium on Dendritic Cells |
| Rendezvény kezdete: 2012.10.07. | Rendezvény vége: 2012.10.11. |
| Munkahely neve: DC 2012 Secretariat |
| Címe: 1F Haeoreum B/D 748-5 Yeoksam-dong
Gangnam-gu Seoul 135-925 Korea |
| Tel: +82-2-577-8422,8423 |
| Fax: +82-2-566-6087 |
| E-mail: dc@people-x.com |
| Helyszín: Korea, Daegu, EXCO Convention Center |
| A rendezvény Web oldala: http://www.dc2012.kr/ |
The 12th International Symposium on Dendritic Cells
The DC2012 is hosted by the Korean Association of Immunologists and organized by the
Organizing Committee of the DC 2012.
The DC 2012 is anticipating more than 1,600 participants and industry representatives from 40
different countries. I truly believe that DC2012 would be the milestone for all of us to understand the
cutting-edge of research trends, to share valuable information and to build a network between
specialists in the field of dendritic cells.
Deadline of Abstract Submission is extended to June 30, 2012
re-registration: Extended to Sep. 14th, 2012!
Clinical Trial Satellite Meeting(Sponsored by JW CreaGene, BD)
*Date & Time: October 8~9, 2012 / 12:20~13:20
*Venue: 4F Auditorium, EXCO
*Confirmed Speakers:
1)TriMix Dentritic cell therapy in Melanoma - the Brussels`s experience
-Prof. Thielemans Kris (Vrije Universiteit Brussel, Belgium)
2)Applying Lessons learned from Provenge to the development of new immunotherapies for cancer
-Dr. James B. Trager (Dendreon Corporation, USA)
-The lunch will be served during the Clinical Trial Satellite Meeting.
-Maximum 300 persons can attend the meeting on a first-come, first-served basis. |
|
|
|
